216 related articles for article (PubMed ID: 24622469)
1. Association of pancreatic Fatty infiltration with pancreatic ductal adenocarcinoma.
Hori M; Takahashi M; Hiraoka N; Yamaji T; Mutoh M; Ishigamori R; Furuta K; Okusaka T; Shimada K; Kosuge T; Kanai Y; Nakagama H
Clin Transl Gastroenterol; 2014 Mar; 5(3):e53. PubMed ID: 24622469
[TBL] [Abstract][Full Text] [Related]
2. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans.
Takahashi M; Hori M; Ishigamori R; Mutoh M; Imai T; Nakagama H
Cancer Sci; 2018 Oct; 109(10):3013-3023. PubMed ID: 30099827
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic Fat Infiltration Is Associated with a Higher Risk of Pancreatic Ductal Adenocarcinoma.
Desai V; Patel K; Sheth R; Barlass U; Chan YM; Sclamberg J; Bishehsari F
Visc Med; 2020 Jun; 36(3):220-226. PubMed ID: 32775353
[TBL] [Abstract][Full Text] [Related]
4. Association between hyperechogenic pancreas and pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasms.
Mandai K; Uno K; Nakase K; Kawamura T; Yasuda K
J Med Ultrason (2001); 2019 Oct; 46(4):435-439. PubMed ID: 31069577
[TBL] [Abstract][Full Text] [Related]
5. Fatty Pancreas-Centered Metabolic Basis of Pancreatic Adenocarcinoma: From Obesity, Diabetes and Pancreatitis to Oncogenesis.
Chang ML
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327494
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic fatty degeneration and fibrosis as predisposing factors for the development of pancreatic ductal adenocarcinoma.
Tomita Y; Azuma K; Nonaka Y; Kamada Y; Tomoeda M; Kishida M; Tanemura M; Miyoshi E
Pancreas; 2014 Oct; 43(7):1032-41. PubMed ID: 24991971
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of carcinogenesis and fatty infiltration in the pancreas in N-nitrosobis(2-oxopropyl)amine-treated hamsters by high-fat diet.
Hori M; Kitahashi T; Imai T; Ishigamori R; Takasu S; Mutoh M; Sugimura T; Wakabayashi K; Takahashi M
Pancreas; 2011 Nov; 40(8):1234-40. PubMed ID: 21989024
[TBL] [Abstract][Full Text] [Related]
8. CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma.
Fukuda Y; Yamada D; Eguchi H; Hata T; Iwagami Y; Noda T; Asaoka T; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Mori M; Doki Y
Ann Surg Oncol; 2017 Sep; 24(9):2762-2769. PubMed ID: 28634666
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma.
Malleo G; Mazzarella F; Malpaga A; Marchegiani G; Salvia R; Bassi C; Butturini G
Surgery; 2013 May; 153(5):641-50. PubMed ID: 23276391
[TBL] [Abstract][Full Text] [Related]
10. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the degree of pancreatic fatty infiltration by area-based assessment of CT images: comparison with histopathology-based and CT attenuation index-based assessments.
Hori M; Onaya H; Hiraoka N; Yamaji T; Kobayashi H; Takahashi M; Mutoh M; Shimada K; Nakagama H
Jpn J Radiol; 2016 Oct; 34(10):667-676. PubMed ID: 27581428
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for fatty pancreas and effects of fatty infiltration on pancreatic cancer.
Otsuka N; Shimizu K; Taniai M; Tokushige K
Front Physiol; 2023; 14():1243983. PubMed ID: 37664430
[No Abstract] [Full Text] [Related]
13. Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus.
Kolb A; Rieder S; Born D; Giese NA; Giese T; Rudofsky G; Werner J; Büchler MW; Friess H; Esposito I; Kleeff J
Cancer Biol Ther; 2009 Aug; 8(16):1527-33. PubMed ID: 19571666
[TBL] [Abstract][Full Text] [Related]
14. CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration.
Zhang R; Liu Q; Peng J; Wang M; Li T; Liu J; Cui M; Zhang X; Gao X; Liao Q; Zhao Y
J Cancer; 2020; 11(9):2371-2381. PubMed ID: 32201508
[No Abstract] [Full Text] [Related]
15. Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma.
Chu CK; Mazo AE; Sarmiento JM; Staley CA; Adsay NV; Umpierrez GE; Kooby DA
J Am Coll Surg; 2010 Apr; 210(4):463-73. PubMed ID: 20347739
[TBL] [Abstract][Full Text] [Related]
16. Human pancreatic neuro-insular network in health and fatty infiltration.
Tang SC; Baeyens L; Shen CN; Peng SJ; Chien HJ; Scheel DW; Chamberlain CE; German MS
Diabetologia; 2018 Jan; 61(1):168-181. PubMed ID: 28852792
[TBL] [Abstract][Full Text] [Related]
17. Chronic inflammatory changes and oxidative stress in the background of "pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm".
Matsuda R; Miyasaka Y; Yamada Y; Kawata J; Sakihama K; Yamamoto T; Saeki K; Yamamoto H; Ohishi Y; Koga Y; Nakamura M; Oda Y
Virchows Arch; 2020 Dec; 477(6):799-806. PubMed ID: 32468246
[TBL] [Abstract][Full Text] [Related]
18. Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma.
Busek P; Vanickova Z; Hrabal P; Brabec M; Fric P; Zavoral M; Skrha J; Kmochova K; Laclav M; Bunganic B; Augustyns K; Van Der Veken P; Sedo A
Pancreatology; 2016; 16(5):829-38. PubMed ID: 27320722
[TBL] [Abstract][Full Text] [Related]
19. Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in the Remnant Pancreas.
Matsuda R; Miyasaka Y; Ohishi Y; Yamamoto T; Saeki K; Mochidome N; Abe A; Ozono K; Shindo K; Ohtsuka T; Kikutake C; Nakamura M; Oda Y
Ann Surg; 2020 May; 271(5):941-948. PubMed ID: 30308608
[TBL] [Abstract][Full Text] [Related]
20. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
